Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,273 | 349 | 72.5% |
| Travel and Lodging | $2,077 | 8 | 20.7% |
| Education | $688.57 | 14 | 6.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,716 | 66 | $0 (2024) |
| PROCEPT BioRobotics Corporation | $1,368 | 7 | $0 (2024) |
| Boston Scientific Corporation | $1,274 | 27 | $0 (2024) |
| Janssen Biotech, Inc. | $1,198 | 39 | $0 (2024) |
| ABBVIE INC. | $604.78 | 36 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $529.65 | 15 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $494.86 | 22 | $0 (2024) |
| Allergan, Inc. | $227.10 | 15 | $0 (2020) |
| Rochester Medical Corporation | $223.97 | 18 | $0 (2022) |
| PFIZER INC. | $223.59 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,763 | 68 | PROCEPT BioRobotics Corporation ($1,368) |
| 2023 | $1,672 | 65 | Janssen Biotech, Inc. ($271.47) |
| 2022 | $1,344 | 28 | Boston Scientific Corporation ($837.91) |
| 2021 | $3.82 | 1 | Travere Therapeutics, Inc. ($3.82) |
| 2020 | $493.85 | 25 | Astellas Pharma US Inc ($176.93) |
| 2019 | $1,446 | 73 | Astellas Pharma US Inc ($390.53) |
| 2018 | $1,440 | 66 | Astellas Pharma US Inc ($410.46) |
| 2017 | $874.87 | 45 | Janssen Biotech, Inc. ($257.46) |
All Payment Transactions
371 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/28/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $2.37 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/25/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: HORMONE THERAPY | ||||||
| 10/22/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $27.88 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Oncology | ||||||
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Oncology | ||||||
| 10/04/2024 | Boston Scientific Corporation | Moses 550 DFL (Device) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Moses 550 DFL_URO | ||||||
| 10/02/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Oncology | ||||||
| 09/27/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/24/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $14.28 | General |
| Category: ONCOLOGY | ||||||
| 09/23/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: HORMONE THERAPY | ||||||
| 09/17/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $29.28 | General |
| Category: Oncology | ||||||
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $33.95 | General |
| Category: Oncology | ||||||
| 09/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $105.16 | General |
| Category: UROLOGY | ||||||
| 09/06/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: ONCOLOGY | ||||||
| 08/22/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: ONCOLOGY | ||||||
| 08/19/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Oncology | ||||||
| 08/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $1.89 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Oncology | ||||||
| 07/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/25/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Oncology | ||||||
| 07/03/2024 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: LithoVue_URO | ||||||
| 07/03/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: rezum_URO | ||||||
| 06/24/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $27.28 | General |
| Category: HORMONE THERAPY | ||||||
| 06/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $4.24 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,762 | 3,538 | $544,575 | $138,375 |
| 2022 | 23 | 1,825 | 4,394 | $499,134 | $127,293 |
| 2021 | 24 | 1,696 | 4,447 | $494,111 | $141,031 |
| 2020 | 18 | 1,504 | 2,340 | $341,144 | $106,498 |
All Medicare Procedures & Services
89 procedure records from CMS Medicare Utilization — Page 3 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 75 | 98 | $57,330 | $16,020 | 27.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 61 | 61 | $24,400 | $7,155 | 29.3% |
| 52356 | Crushing of stone in urinary duct (ureter) with stent using an endoscope | Facility | 2021 | 19 | 20 | $28,800 | $6,848 | 23.8% |
| 52310 | Removal of foreign body, stone, or stent from bladder canal (urethra) or bladder using an endoscope | Office | 2021 | 19 | 19 | $14,725 | $4,631 | 31.5% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2021 | 13 | 1,876 | $9,755 | $4,031 | 41.3% |
| 55700 | Biopsy of prostate gland | Office | 2021 | 17 | 17 | $10,540 | $2,897 | 27.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 35 | 35 | $9,310 | $2,783 | 29.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 67 | 72 | $9,720 | $2,723 | 28.0% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2021 | 13 | 43 | $9,675 | $2,635 | 27.2% |
| 51702 | Insertion of indwelling bladder catheter, simple | Office | 2021 | 28 | 55 | $9,625 | $2,444 | 25.4% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2021 | 372 | 605 | $15,125 | $2,415 | 16.0% |
| 52332 | Insertion of stent in urinary duct (ureter) using an endoscope | Facility | 2021 | 15 | 19 | $11,475 | $2,092 | 18.2% |
| 76872 | Ultrasound of pelvic region through rectum | Office | 2021 | 18 | 18 | $6,210 | $1,957 | 31.5% |
| 87086 | Bacterial colony count, urine | Office | 2021 | 89 | 130 | $4,550 | $1,043 | 22.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2021 | 121 | 146 | $7,305 | $1,041 | 14.3% |
| 96402 | Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle | Office | 2021 | 26 | 36 | $3,600 | $836.69 | 23.2% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2021 | 55 | 98 | $3,920 | $835.01 | 21.3% |
| 87088 | Bacterial urine culture | Office | 2021 | 58 | 103 | $3,605 | $821.41 | 22.8% |
| 87077 | Bacterial culture for aerobic isolates | Office | 2021 | 58 | 101 | $3,535 | $804.22 | 22.8% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 11 | 11 | $2,640 | $773.40 | 29.3% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 11 | 11 | $1,903 | $564.80 | 29.7% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2020 | 23 | 218 | $87,200 | $38,694 | 44.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 310 | 427 | $74,725 | $21,183 | 28.3% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2020 | 69 | 82 | $41,000 | $11,835 | 28.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 105 | 123 | $31,980 | $9,045 | 28.3% |
About Dr. Bradley Warner, M.D
Dr. Bradley Warner, M.D is a Urology healthcare provider based in Salem, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/04/2008. The National Provider Identifier (NPI) number assigned to this provider is 1417100405.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bradley Warner, M.D has received a total of $10,038 in payments from pharmaceutical and medical device companies, with $2,763 received in 2024. These payments were reported across 371 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($7,273).
As a Medicare-enrolled provider, Warner has provided services to 6,787 Medicare beneficiaries, totaling 14,719 services with total Medicare billing of $513,196. Data is available for 4 years (2020–2023), covering 89 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Salem, OR
- Active Since 11/04/2008
- Last Updated 03/10/2016
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1417100405
Products in Payments
- AQUABEAM SYSTEM (Device) $1,368
- GreenLight XPS (Device) $837.91
- XTANDI (Drug) $743.24
- Erleada (Drug) $536.84
- PROVENGE (Drug) $494.86
- BOTOX (Biological) $486.03
- Myrbetriq (Drug) $415.47
- ZYTIGA (Drug) $380.97
- ERLEADA (Drug) $348.51
- GEMTESA (Drug) $295.60
- ORGOVYX (Drug) $271.78
- MYRBETRIQ (Drug) $245.01
- ELIGARD (Drug) $206.44
- LYNPARZA (Drug) $192.95
- REZUM (Device) $181.93
- Nubeqa (Drug) $118.05
- Xtandi (Drug) $115.20
- BOTOX THERAPEUTIC (Biological) $112.92
- YONSA (Drug) $97.00
- FIRMAGON (Drug) $96.62
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Salem
Dr. Mark Laspina, D.o, D.O
Urology — Payments: $19,777
Stuart Diamond, Md, MD
Urology — Payments: $18,471
Dr. Alejandra Balen, M.d, M.D
Urology — Payments: $14,486
Mr. Noel Defelippo, Md, MD
Urology — Payments: $8,224
Dr. John Mhoon, M.d, M.D
Urology — Payments: $7,907
Mr. Thomas Kingston, Md, MD
Urology — Payments: $6,356